We will further study the pharmacologic action and molecular mechanism of FABP3-targeted compounds to prevent dopaminergic neurons from α-synuclein propagation and to promote neuronal survival [50,160,161,162,163,164], and we will develop a diagnostic method for predicting PD at the very early stages. Here, SNCA is linked to Parkinson disease.